Find your next paid study

University of California, Los AngelesNCT00695214

Phase 4

Comparative Effectiveness of Positive Airway Pressure Therapy, Dental Device, and Atomoxetine-Oxybutynin for Sleep Apnea: the ADAPT-OSA Study

Researchers want to identify which treatments for obstructive sleep apnea (OSA) work best and are easiest for patients to use consistently. Eligible participan…

Obstructive Sleep Apnea (OSA)

Sairam ParthasarathyNCT07679282

~$10 – $7,500

Phase 4

Treatment of Sleep Apnea in Patients With Cervical Spinal Cord Injury

This study will investigate potential therapeutic approaches for sleep-disordered breathing (SDB) in patients with chronic cervical spine injury (\>6 months po…

Sleep ApneaSpinal Cord Injury

John D. Dingell VA Medical CenterNCT02922894

Phase 2

Endotypic Traits and Obstructive Sleep Apnea Surgery

This study will examine factors associated with outcomes after soft palate surgery and medications (acetazolamide, eszopiclone) that may treat other potential …

University of California, Los AngelesNCT05953610

Observational

Myofunctional Therapy for Obstructive Sleep Apnea

The purpose of this study is to explore a new way to examine the function of the muscles using a technique called high-resolution manometry. The study will enr…

University of MinnesotaNCT07301125

Phase 1

Targeting Chemoreceptor Control of Breathing During Sleep to Mitigate Opioid-Associated Sleep Disordered Breathing

There is an increased risk for sleep disordered breathing (SDB), sleep-related hypoventilation and irregular breathing in individuals on chronic prescription o…

Sleep ApneaOpioid UseSleep Disordered Breathing

VA Office of Research and DevelopmentNCT05589753

~$10 – $5,625

Observational

Ansa Cervicalis and Hypoglossal Nerve Stimulation in Obstructive Sleep Apnea

Polysomnography (PSG) and drug-induced sleep endoscopy (DISE) are widely used diagnostic studies for assessing obstructive sleep apnea (OSA) severity and colla…

Vanderbilt University Medical CenterNCT05501236

Phase 2

Impact of Acetazolamide on Central Sleep Apnea Patients Receiving Medication for Opioid Use Disorder

Patients with opioid use disorder treated with either methadone or buprenorphine are at risk of developing central sleep apnea (CSA) from these medications. In…

Central Sleep Apnea Comorbid With Opioid Use

Sanjay R PatelNCT06521476

~$10 – $7,500

Development of a Wearable Point of Care Monitoring Device for Pediatric Obstructive Sleep Apnea

Background: Obstructive sleep apnea (OSA) occurs when the blockage of the airway causes a person to stop breathing involuntarily for 10 seconds or more throug…

Pediatric Obstructive Sleep Apnea

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NCT05052216

~$10 – $675

Phase 3

A Master Protocol for Phase 3 Randomized, Double-Blind, Placebo-Controlled Studies to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Moderate to Severe Obstructive Sleep Apnea, and Obesity or Overweight

The purpose of the studies is to evaluate the efficacy and safety of eloralintide in participants with moderate-to-severe obstructive sleep apnea and obesity o…

Sleep Apnea, ObstructiveObesityOverweight

Eli Lilly and CompanyNCT07369011

~$10 – $7,500

Phase 2

Mouth Tape for Snoring and Sleep Apnea (MTASSA)

Snoring is a common problem caused by vibration of tissues in the throat region during sleep. Although snoring is sometimes dismissed as a minor nuisance rathe…

Mild Obstructive Sleep ApneaSnoring

Johns Hopkins UniversityNCT06587256

Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation

The objective of the BREATHE study is to demonstrate the continued safety and effectiveness of the Genio® System in treating subjects diagnosed with moderate t…